Latest Breaking News On - Forbion general partner dmitrij hristodorov - Page 1 : comparemela.com

Progentos Therapeutics, a biotech company addressing the critical unmet need to regenerate myelin and restore function for patients with Multiple Sclerosis (MS) and other demyelinating diseases, today announced its launch and the closing of a $65.

United statesNoord hollandDmitrij hristodorovProduct serviceMission biocapitalLongwood fundTherapeutics closesAdvance treatmentsMultiple sclerosisChris looseNetherlands based forbionAlta partnersDolby familyForbion general partner dmitrij hristodorov